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ScienceDirectWnt morphogens are secreted signalling proteins that play
leading roles in embryogenesis and tissue homeostasis
throughout life. Wnt signalling is controlled by multiple
mechanisms, including posttranslational modification of Wnts,
antagonist binding (to Wnts or their receptors), and regulation
of the availability of Wnt receptors. Recent crystallographic,
structure-guided biophysical and cell-based studies have
advanced our understanding of how Wnt signalling is regulated
at the cell surface. Structures include Wnt in complex with the
cysteine-rich domain (CRD) of Frizzled, extracellular fragments
of Wnt co-receptor LRP6, LRP6-binding antagonists Dickkopf
and Sclerostin, antagonists 5T4/WAIF1 and Wnt inhibitory
factor 1 (WIF-1), as well as Frizzled–ubiquitin ligases ZNRF3/
RNF43 (in isolation and in complexes with Wnt signalling
promoters R-spondins and LGR5). We review recent
discoveries and remaining questions.
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Introduction
Wnt morphogens play leading roles in embryonic
development as well as in adult stem cell biology. Con-
versely, components of Wnt signalling pathways are
frequently mutated in cancers, particularly those of
tissues for which Wnts normally stimulate self-renewal
and repair (reviewed in [1,2]). Importantly, in terms of
the potential for targeting Wnts and their receptors for
therapeutic intervention, autocrine Wnt signalling is
necessary for the proliferation and/or survival of many
types of tumours [3]. The disparate mechanisms which
provide extracellular regulation of Wnt signalling are
therefore of considerable interest as possible templates
for the development of novel therapeutics.www.sciencedirect.com Wnts signal through several distinct pathways, the best
characterised being the canonical Wnt/b-catenin path-
way. Canonical Wnt signalling is triggered by the binding
of Wnt ligand to two cell surface receptors: a seven-pass
transmembrane receptor of the Frizzled family and either
one of two closely related type 1 transmembrane recep-
tors of the LDL-receptor-related protein (LRP) family,
LRP5 or LRP6. Signal transduction by the ternary
Frizzled–Wnt–LRP5/6 complex involves phosphoryla-
tion of the LRP5/6 cytoplasmic region, which leads to
the recruitment of Axin, a central component of the b-
catenin destruction complex, and, ultimately, migration
of b-catenin to the nucleus (reviewed in [1,4]). This
process is tightly regulated by a complex network of
extracellular agonists and antagonists (reviewed in [5])
including one recently discovered Wnt protease, TIKI,
which has prompted the definition of a new enzyme
superfamily [6–8]. A number of secreted proteins act
directly as antagonists by binding to Wnts. Members of
a second class of antagonists bind to LRP5/6, preventing
engagement by Wnts. Removal of the receptors from the
cell surface through the targeted activity of cell mem-
brane spanning E3 ubiquitin ligases provides a third,
recently discovered, regulatory mechanism. In turn, this
mechanism is targeted by a family of secreted Wnt signal
promoters, the R-spondins. Recent structure determi-
nations have provided major insights into molecular
mechanism for several components of this multilayered
control system. In the following sections we review these
advances.
Wnt and Norrin, two unrelated ligands for
Frizzled receptors?
The members of the Frizzled family of Wnt receptors
contain a distinctive CRD in their N-terminal extracellu-
lar segment. Over a decade ago, Leahy and co-workers
determined the structure of the CRD for mouse Frizzled8
(Figure 1) and identified a putative Wnt-binding site [9].
The structure of Wnt eluded determination until the
groundbreaking publication by Garcia and colleagues in
2012 of Xenopus Wnt8 in complex with the CRD of mouse
Frizzled8 [10]. The Wnts are also cysteine-rich and bear
post-translational lipid modifications, characteristics that
have caused substantial headaches for researchers seek-
ing to generate the quantities and concentrations of
homogeneous, pure protein required for structural anal-
yses. For the Wnt8 structure determination, the key
approach to overcome these obstacles was to work with
Wnt in complex with Frizzled CRD. The structure
reveals a palmitoleoyl moiety covalently linked to serine
187 in Wnt8. This palmitoleoyl group is central to one of
two distinct Wnt–Frizzled CRD interfaces in the 1:1Current Opinion in Structural Biology 2014, 29:77–84
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Activators and inhibitors of the Wnt/b-catenin signalling pathway. (a) Lipid-modified Wnt protein (green; palmitoleoyl group is shown in red) binds to
Frizzled CRD, LRP6 b-propellers 1–2 and/or 3–4, and triggers downstream signalling. CRD of Wnt receptor Frizzled8 is shown in light blue, four b-
propellers of co-receptor LRP6 are shown in dark blue. Hinge region between b-propellers 1–2 and 3–4 is shown as a blue dot. Dimeric signalling
activator Norrin (monomers shown in magenta and grey) binds specifically to Frizzled4 (grey) and LRP6 b-propellers 1–2. Dotted lines represent
interactions between molecules where crystal structures of the complexes are absent. (b) Extracellular inhibitors bind to Wnt co-receptor LRP6 or Wnt
and prevent them from triggering signalling. Both Sclerostin and Dickkopf (Dkk) contain an Asn-X-Ile motif (peptide shown as connected yellow
spheres) recognized by LRP6 b-propeller 1. The C-terminal domain of Dkk1 (red) binds to LRP6 b-propeller 3. WIF1 (pink; WIF1-bound DPPC, light
blue) and secreted Frizzled related protein 3 (sFRP3 CRD, teal) prevent signalling by binding to Wnts. WIF1 binds to HS chains of HSPGs (grey).
Sclerostin (as well as other activators and inhibitors) bind to HS-mimic, heparin. Signalling inhibitor 5T4/Wnt-activated inhibitory factor 1 (WAIF1,
purple) acts via unknown binding partners. Structures used: Frizzled8, Wnt8 ([10]; PDB ID 4F0A); LRP6 b-propellers 1–2 ([24]; 3S94); LRP6 b-
propellers 3–4 ([29]; 4A0P), Norrin ([14]; 4MY2), LRP6 b-propeller 1–Sclerostin-derived peptide ([28]; 3SOV); LRP6 b-propellers 3–4–Dickkopf
([23]; 3S2K); Sclerostin ([25]; 2K8P); WIF1 ([16]; 2YGQ); sFRP3 CRD ([9]; 1IJX); 5T4/WAIF1 ([31]; 4CNM).
Current Opinion in Structural Biology 2014, 29:77–84 www.sciencedirect.com
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‘tweezer-type’ architecture which grips the segment of
receptor between two slender digit-like b-hairpin loops,
the so-called thumb (with lipidated Ser187 at its tip) and
finger. The thumb protrudes from an N-terminal domain
which bears the evolutionarily distant hallmarks of a
saposin-like fold, the finger is provided by the C-terminal
domain, which shares the topology of cystine-knot cyto-
kines such as platelet derived growth factor. Thus Wnt
comprises an intriguing juxtaposition of lipid associated
saposin fold and receptor-binding cytokine fold [11].
The relatively discrete nature of the N-terminal and
C-terminal halves of the Wnt topology is clearly demon-
strated by the recent determination of a standalone
structure of the N-terminal segment of Drosophila WntDFigure 2
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Atomic details of Wnt recognition and signalling inhibition. (a) Zoom-in
view of the palmitoleoyl binding site in the CRD of Frizzled8. Molecules
are coloured as in Figure 1. The Ser187-linked palmitoleoyl group is
shown as connected red spheres. Frizzled8 CRD residues forming the
hydrophobic groove are shown as sticks (carbon, blue; oxygen, red) and
numbered. Boundaries of the lipid-binding groove are marked with grey
lines. (b) WIF domain of WIF-1 forms a hydrophobic pocket which
accommodates DPPC (carbon, grey; oxygen, red; phosphorus, orange;
nitrogen, blue). The head group of DPPC is exposed to the solvent and
located proximal to the putative Wnt3a binding site. (c) The first b-
propeller of LRP6 recognizes an evolutionarily conserved tripeptide motif
Asn-X-Ile (X, variable amino acid) present in two inhibitors of Wnt
signalling, Dickkopf1 and Sclerostin. A peptide derived from human
Sclerostin (residues Leu115–Arg121) is shown as sticks (carbon, yellow;
oxygen, red; nitrogen, blue). Three residues of LRP6 forming hydrogen
bonds with Sclerostin peptide are shown as sticks.
www.sciencedirect.com [12]. A comparison of the structures of Wnt8 and the WntD
segment highlights the linker between the N-terminal
and C-terminal domains as a putative LRP6-binding site.
This hypothesis is supported by mutagenesis-based
analyses of Wnt3a [12], but as yet there is no direct
structural data on the interaction of the Wnts with their
LRP5/6 co-receptor.
The 19 human Wnts are rather promiscuous, each being
able to bind to more than one of the 10 Frizzled family
members, consistent with relatively high levels of conser-
vation in the binding interface [10]. Norrin, a ligand
which shows no relationship to the Wnts in sequence
analyses, can also activate the Wnt/b-catenin pathway
by binding to the Wnt receptors, but signalling complex
formation is specific for Norrin–Frizzled4 [13]. Like Wnt,
Norrin also presents substantial challenges for over-expres-
sion and purification. Xu and co-workers have recently
reported expression (in Escherichia coli) and crystal struc-
ture determination of Norrin fused to the C-terminus of
maltose-binding protein [14]. This structure reveals a
dimer formed by two intertwined monomers locked
together by three intermolecular disulfide bonds
(Figure 1a). Norrin had been predicted to have structural
homology to the cystine-knot cytokines, and the crystal
structure confirmed that indeed it does have this general
topology. Nevertheless, the arrangement of three inter-
molecular disulfide bonds is completely unexpected and,
to date, unique. The identification of the cytokine-type
fold in the C-terminal domain of the Wnts reveals an
unsuspected structural similarity between Wnt and Norrin.
It will be very interesting to see what additional structural
parallels emerge from future studies of the assembly of
Frizzled and LRP5/6 signalling complexes involving these
two distinctive ligands.
Wnt-binding antagonists, themes of
modularity and HSPG-binding
Members of several protein families can act as secreted
antagonists that bind directly to the Wnts to block for-
mation of the Frizzled–Wnt–LRP5/6 complex [5]. These
include the secreted Frizzled-related proteins (sFRPs)
and WIF-1. The crystal structure of mouse sFRP3 CRD,
determined alongside that of the CRD for mouse Frizzled8,
revealed a conserved topology. This conservation
suggested that sFRPs down regulate Wnt signalling by
competing with the Frizzled receptors for Wnt binding [9].
In addition to the N-terminal CRD, sFRPs contain a C-
terminal Netrin-like domain (NTD) which has been impli-
cated not only in the interaction of sFRPs with some Wnts,
but also in interactions with a range of molecules including
heparin (reviewed in [15]). Heparin is a highly sulphated
glycosaminoglycan and is structurally similar to the heparan
sulphate (HS) chains covalently linked to HS proteoglycans
(HSPGs, Figure 1b). The structural determinants under-
lying the contributions and interplay of the CRD and NTD
in the function of sFRPs await characterisation.Current Opinion in Structural Biology 2014, 29:77–84
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types of domains: the signature WIF domain and five
epidermal growth factor (EGF)-like domains. Surprisingly,
our structural studies of WIF-1 revealed 1,2-dipalmitoyl-
phosphatidylcholine (DPPC) bound to WIF-1 (Figures 1b
and 2b; [16]). The two palmitoyl chains of the DPPC
extend deep into the WIF domain, while the choline head
group is exposed on the protein surface. Structure-guided
biophysical and cellular assays implicate this region of the
WIF domain surface in Wnt3a binding. Although NMR-
based studies of refolded WIF domain had previously
suggested tight association could occur between the
domain and the detergent Brij-35 [17], focusing interest
onto possible lipid-binding functionalities [18,19], the
discovery of the major lipid-binding cavity in the crystal
structure of the mammalian cell expressed WIF-1 was
unexpected [16]. DPPC appears to be an integral com-
ponent of the WIF-1 WIF domain. An exchange of the
WIF-1-bound diacyl lipid with a single chain Wnt-linked
palmitoleoyl moiety would be energetically unfavourable
in the aqueous environment, arguing against palmitoleoyl-
mediated sequestration of Wnt by WIF-1 [16]. However,
WIF domains are present in several evolutionarily diver-
gent proteins, including the ectodomains of RYK receptors
involved in non-canonical Wnt signalling, raising the inter-
esting possibility that in some cases a WIF domain might
sequester the Wnt-linked palmitoleoyl moiety within this
lipid-binding cavity.
EGF-like domains II–V of WIF-1 contain a HS-binding
site. This combination of HS-binding and Wnt-binding
properties led us to propose a role for HS mediated co-
localization of WIF-1 and Wnt in promoting inhibition
[16]. Indeed HS-binding is a recurring theme in the
interaction repertoire of the extracellular components of
the Wnt system, with recent results pointing to its direct
role in signal modulation [20,21]. Thus the WIF-1 model
for agonist and antagonist co-localization via protein–HS
interactions may be a broadly applicable paradigm in the
regulation of Wnt signalling.
The extracellular structure and multiple
interactions of LRP5/6
The Wnt co-receptors LRP5 and LRP6 also bind to
secreted inhibitors of Wnt signalling, Dickkopf and Scler-
ostin. The four vertebrate Dickkopfs contain two con-
served CRDs (which are not related to the Frizzled CRD
fold). The LRP5/6 binding properties and structure of the
C-terminal domain of Dickkopf1 have been analysed in
detail ([22,23,24]; Figure 1b). Sclerostin has the cyto-
kine cystine-knot topology but, unusually for proteins
with this fold, is monomeric ([25,26]; Figure 1b).
Amino acid sequence analysis characterises the LRP5/6
ectodomain as four tandem b-propeller–EGF-like
domain (PE) pairs followed by three LDLR-type A
repeats. Binding studies established that the PE unitsCurrent Opinion in Structural Biology 2014, 29:77–84 harbour interaction sites for Wnt proteins and their
antagonists [27] and, as a result, these segments of the
LRP5/6 ectodomain have been a focus for structural
analyses. A series of studies have provided structures of
the PEs in isolation and in complex with a variety of
ligands [23,24,28,29,30] (Figures 1 and 2c). The
PE units associate as pairs through an extensive inter-pair
interface, conserved for the first-to-second and third-to-
fourth PE interactions. We combined crystallographic
structure determination of the third and fourth PE pair
with a low resolution negative stain electron microscopy
analysis of the full-length extracellular segment of LRP6
to reveal the PE pairs arranged in a rather compact
platform-like ectodomain conformation [29]. This plat-
form architecture appears well suited to support the
interplay of ligands at multiple recognition sites which
is emerging as a salient theme in Wnt signalling.
Data from cellular and binding assays map overlapping
Wnt3a-binding and Dkk1-binding surfaces on the third
PE of LRP5/6, consistent with inhibition through steric
competition [29]. However, as seems to be often the
case for the Wnt signalling system, the overall picture is
more complex. LRP6–Dickkopf1 interactions highlight
the ability of Dickkopf1 to inhibit multiple Wnts that
signal through (and bind to) distinct PE pairs of LRP6.
For example, Wnt3a binds to PEs 3–4, but not PEs 1–2,
whereas Wnt9b binds to PEs 1–2, but not to PEs 3–4 [27].
Dickkopf1 binds to both PEs 1–2 and PEs 3–4, and thus
competes with both Wnt3a and Wnt9b for LRP6 binding
[27].
The recent structural studies of LRP5/6 interaction com-
plexes now reveal how the two conserved CRDs of
Dickkopf1 contribute to the inhibition of Wnt signalling.
Crystallographic studies showed the C-terminal domain
of Dickkopf1 bound to LRP6 b-propeller 3 (Figure 1b;
[23,24]), whereas a peptide derived from the N-term-
inal domain of Dickkopf bound to LRP6 b-propeller
1 [28]. Intriguingly, the Dickkopf1-derived peptide
recognized by LRP6 b-propeller 1 contains an evolutio-
narily conserved motif Asn-X-Ile (X, variable amino acid)
which is present in the otherwise structurally unrelated
Wnt signalling inhibitor, Sclerostin (Figures 1b and 2c;
[28]). Structural and functional analyses have confirmed
that this motif plays a major role in Sclerostin–LRP5/6
binding [28,30]. The functional implications of Asn-X-
Ile recognition are further underlined by the clustering of
human mutations associated with high bone-mass density
disorder to the tri-peptide binding pocket in LRP5
b-propeller 1 [23,29]. Doubtless future studies will
continue to expand the repertoire of LRP5/6 interactions
as well as reveal additional shared features.
One mechanism for Wnt signalling inhibition that
remains enigmatic is that of the cell surface protein
5T4/WAIF1. Distinct surface regions on the 5T4/WAIF1www.sciencedirect.com
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are implicated in Wnt antagonism ([31]; Figure 1b),
however, the protein(s) which bind these surfaces have
as yet eluded identification.
E3 ubiquitin ligases, the R-spondins and
LGR4/5/6
In addition to direct Wnt and Wnt receptor binding by
antagonists, ubiquitination  and degradation of Wnt re-
ceptor Frizzled provide an additional mechanism by
which Wnt signalling can be modulated. ZNRF3 and
RNF43 are members of a family of E3 ubiquitin ligases
which have a signature N-terminal ectodomain and
transmembrane region in addition to the RING finger
domain-bearing cytoplasmic region. Both ZNRF3 and
RNF43 have recently been found to act specifically on
Frizzled, reducing Wnt signalling by ubiquitination and
consequent removal of Wnt receptors from the cell
surface [32,33]. The identification of a ZNRF3/
RNF43 homologue in Caenorhabditis elegans, PLR-1,
indicates that this novel regulation mechanism is con-
served across invertebrate and vertebrate Wnt signalling
systems [34]. Structural analyses have rapidly focused on
this newly discovered control point. Crystal structures of
the ZNRF3/RNF43 ectodomain show a relatively com-
pact architecture with the topology of a protease-associ-
ated (PA) domain (Figure 3a; [35,36,37]). Although
ZNRF3 and RNF43 appear structurally very similar,
there is one curious difference. The ZNRF3 ectodo-
main shows a propensity to dimerise, which is not shared
by RNF43 [36]. The ectodomain, as well as the
RING finger domain, is required for ZNRF3/RNF43/
PLR-1 ubiquitin ligase activity [32–34], suggesting that
the PA domain is involved in targeting Frizzled. To
date, the molecular determinants of this targeting inter-
action have not been analysed in detail. However, an
associated set of regulatory interactions, specific to
mammals, has triggered a further flurry of structure
determinations.
The four R-spondin proteins are secreted agonists of
canonical Wnt signalling (reviewed in [38]). However,
until recently their mode of action has remained obscure.
There is now a substantial corpus of data showing that the
leucine-rich repeat containing G protein-coupled recep-
tors 4, 5 and 6 (LGR4/5/6) serve as high-affinity cell
surface receptors for the R-spondins [39–43]. Further-
more, R-spondins have been shown to inhibit ZNRF3/
RNF43 activity through direct interactions which gener-
ate ternary complexes comprising ZNRF3/RNF43,
R-spondin and LGR4/5/6 [32]. In total, the data suggest
a model for R-spondin mediated enhancement of Wnt
signalling in which ternary complex formation triggers
membrane clearance of ZNRF3/RNF43 with resultant
accumulation of cell surface Frizzled and LRP5/6 recep-
tors. A cascade of recent structural results has provided uswww.sciencedirect.com with fundamental insights into these R-spondin-depend-
ent regulatory interactions.
Sequence analyses classify the domain structure of the
R-spondins as comprising two furin-like cysteine rich
regions (Furin1–Furin2) plus a thrombospondin type
1 repeat domain. Of these units, the Furin1–Furin2
segment is sufficient to mediate functional interactions
with ZNRF3/RNF43 and LGR4/5/6. Multiple crystal
structures by us and others have recently revealed the
structure of the R-spondin Furin1–Furin2 segment and
its mode of binding with ZNRF3/RNF43 [35,36,37]
and LGR4/5/6 [35,44,45,46] (Figure 3b). In the
ZNRF3/RNF43–R-spondin complexes, a prominently
exposed loop from R-spondin Furin1 is inserted into
equivalent grooves in the surfaces of the ZNRF3 and
RNF43 ectodomains. Intriguingly, we found that ligand
binding enhances dimerization of the ZNRF3 ectodo-
main, but not of the RNF43 ectodomain [36]. To date,
all crystal structures of ZNRF3–R-spondin complexes
show a ZNRF3 dimer binding two R-spondin monomers
[36,37]. The structures of LGR4 and LGR5 ectodo-
mains, as expected from sequence analyses, show the
characteristic curved horseshoe shape of a series of
leucine-rich repeats (in this case seventeen repeats)
with N-terminal and C-terminal caps; R-spondin
Furin1-Furin2 binds to the concave surface [35,44,
45,46]. The R-spondin–LGR4/5/6 interface is in large
part mediated by R-spondin Furin2, and key determi-
nants are conserved across the four R-spondins and
LGR4/5/6, consistent with the observed promiscuity
of binding.
The binding sites of ZNRF3/RNF43 and LGR4/5/6 on
R-spondin Furin1–Furin2 are distinct and positioned such
that the R-spondin can serve as a bridging protein to form a
1:1:1 ternary complex for RNF43–R-spondin–LGR5
(Figure 3b; [35]). The wealth of structural information
now available for various combinations of members of
these three protein families has, however, generated some
significant puzzles concerning oligomeric states. Structural
studies suggest that ZNRF3 ectodomain dimerization is
conserved across evolution from fish to mammals, prompt-
ing the notion that this interaction has some functional role
[36]. Furthermore, a simple modelling exercise demon-
strates that ZNRF3 dimers can be incorporated into the
ternary complex architecture to generate a 2:2:2 assembly
of ZNRF3–R-spondin–LGR4/5/6 [36]. Could the oligo-
meric state of RNF43 and ZNRF3 have an effect on their
function? The presence of 2:2 arrangements of the
R-spondin1–LGR5 complex in four independent crystal
structures poses a somewhat similar conundrum regarding
putative biological role [45]. In this case, the 2:2 arrange-
ment is not compatible with the ternary complex archi-
tecture. However, a role for the R-spondin1–LGR5
dimer-of-dimers may yet emerge from the complexities
of the Wnt signalling system.Current Opinion in Structural Biology 2014, 29:77–84
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Figure 3
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Regulation of Wnt signalling by R-spondin and its receptors. (a) Transmembrane ubiquitin (Ub, shown in grey) E3 ligases ZNRF3 (brown) and RNF43
(red) ubiquitinylate Frizzled thus promoting its endocytosis and inhibition of Wnt signalling. Cytoplasmic regions of both ligases contain RING domains
required for ubiquitinylation. The extracellular domains of ZNRF3 form weak dimers in solution (protomers are shown in brown and grey, respectively;
[36]). (b) R-spondin 1 (RSPO1, green) forms a ternary complex with RNF43 and LGR5 (blue) [35]. Endocytosis of RNF43 and ZNRF3 in complex with
RSPOs and LGRs 4–6 prevents ubiquitinylation of Frizzled and promotes Wnt signalling. Dotted lines represent interactions between molecules where
crystal structures of complexes are not determined. Structure used: ZNRF3 ([36]; PDB ID 4C99); RNF43, RSPO1, LGR5 ([35]; 4KNG); Wnt8,
Frizzled8 and LRP6 are represented as in Figure 1.Conclusions and future perspectives
Tremendous progress has been made in structural studies
of Wnt signalling receptors and modulators during the
past five years. A series of structures of the Wnt
co-receptor LRP6, agonists and antagonists, and, remark-
ably, the first crystal structure of a Wnt family member,Current Opinion in Structural Biology 2014, 29:77–84 Wnt8, in complex with the Frizzled8 CRD, provide
invaluable insights into the basic mechanisms of Wnt
signalling activation and regulation. In 2012, a novel
mechanism of Wnt signalling regulation was discovered
which centres on the interactions of the ZNRF3/RNF43
E3 ubiquitin ligases, the R-spondins and LGR4/5/6.www.sciencedirect.com
Extracellular modulators of Wnt signalling Malinauskas and Jones 83These proteins immediately became a focus for structural
analyses, which have rapidly shed light on multiple inter-
actions and complexes. In terms of future work, many
major questions remain. What are the structural determi-
nants of ZNRF3/RNF43 interactions with the Wnt re-
ceptor Frizzled as well as Wnt interactions with LRP5/6?
Oligomeric states have emerged as a recurrent theme to be
addressed in studies of Wnt receptor signalling and
ZNRF3–R-spondin–LGR4/5/6 function. We look forward
to the insights into these multi-component cell surface
assemblies which structural studies combined with
advanced light microscopy will provide.
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